<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03710590</url>
  </required_header>
  <id_info>
    <org_study_id>HM20012738</org_study_id>
    <secondary_id>U54DA036105</secondary_id>
    <nct_id>NCT03710590</nct_id>
  </id_info>
  <brief_title>Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users</brief_title>
  <official_title>Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to find out how different types of electronic&#xD;
      cigarettes (ECIG) settings, combined with e-liquids of differing nicotine concentrations,&#xD;
      affect blood nicotine levels, use behavior (how users puff), and how users feel.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Actual">March 9, 2020</completion_date>
  <primary_completion_date type="Actual">March 9, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The purpose of this study is to determine differences in nicotine delivery, use behavior (puff topography), carbon monoxide delivery, subjective effects, and physiological effects, when cigarette smokers and experienced electronic cigarette users use an electronic cigarette with different settings (different voltage and resistance settings, which together determine power levels) and different e-liquid concentrations.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will be blinded to the power level and nicotine concentration used in each session.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Plasma Nicotine</measure>
    <time_frame>Baseline to 5 min after the start of a 10-puff product use</time_frame>
    <description>Change in plasma nicotine level.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Puff Volume</measure>
    <time_frame>Each time the e-cigarette is used during the 10-puff use bout - 5 minutes</time_frame>
    <description>The average volume of each puff, in ml, during 10 puff bout.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Puff Duration</measure>
    <time_frame>Each time the e-cigarette is used during the 10-puff use bout - 5 minutes</time_frame>
    <description>The average duration of each puff, in seconds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Heart rate will be measured from baseline continuously throughout the 10-puff bout - 5 minutes</time_frame>
    <description>Average heart rate, measured in beats per minute.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Inter Puff Interval</measure>
    <time_frame>Inter puff interval will be measured each time the e-cigarette is used during an approximately 4 hour session: during a 5-minute 10-puff use bout, and during an approximately 90 minute ad lib use period</time_frame>
    <description>The time between each puff, in seconds</description>
  </other_outcome>
  <other_outcome>
    <measure>Flow Rate</measure>
    <time_frame>Flow rate will be measured each time the e-cigarette is used during an approximately 4 hour session: during a 5-minute 10-puff use bout, and during an approximately 90 minute ad lib use period</time_frame>
    <description>The rate of air flow during each puff, in ml/second</description>
  </other_outcome>
  <other_outcome>
    <measure>Hughes-Hatsukami Questionnaire</measure>
    <time_frame>Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.</time_frame>
    <description>This scale is used to assess the extent to which product use reduces tobacco abstinence symptoms, and consists of 11 items scored 0 - 100, with lower scores indicating less severe symptoms. There are no sub-scales. Items are analyzed separately.</description>
  </other_outcome>
  <other_outcome>
    <measure>Direct Effects of Product Use Questionnaire</measure>
    <time_frame>Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approximately 1-hour ad lib use period.</time_frame>
    <description>This scale is used to assess how product use makes participants feel and consists of 10 questions that are scored 0 - 100. There are no sub-scales. Items are analyzed separately.</description>
  </other_outcome>
  <other_outcome>
    <measure>Direct Effects of Nicotine Questionnaire</measure>
    <time_frame>Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.</time_frame>
    <description>This scale is used to assess how product use makes participants feel, and consists of 10 questions that are scored 0 - 100.There are no sub-scales. Items are analyzed separately.</description>
  </other_outcome>
  <other_outcome>
    <measure>Carbon Monoxide Levels</measure>
    <time_frame>Carbon monoxide levels will be assessed before and after product use in each approximately 4-hr session: at baseline, 5 min after the end of a 10-puff product use, and then before and after an approximately 1-hour ad lib use period.</time_frame>
    <description>Change in carbon monoxide levels (in parts per mission)</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Blood pressure will be measured from baseline continuously throughout each approximately 4-hr session</time_frame>
    <description>Change in blood pressure, measured in mm/hg</description>
  </other_outcome>
  <other_outcome>
    <measure>General Labeled Magnitude Scale</measure>
    <time_frame>The General Labeled Magnitude Scale will be administered twice in each approximately 4 hour session--after a 5-minute 10 puff use bout, and after the approximately 90 minute ad lib period.</time_frame>
    <description>This scale measures the flavor sensation, harshness, and throat hit (in three questions that correspond to those constructs) of the e-cigarette used in each session. The scale ranges from 0 - 100, with 0 being no sensation and 100 being the strongest imaginable sensation of any kind. Each item if scored nd analyzed separately (there are no sub-scales).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Electronic Cigarettes</condition>
  <arm_group>
    <arm_group_label>Cigarette smokers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Electronic cigarette users</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECIG Lab Session 15 watts, 10 mg nicotine</intervention_name>
    <description>During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.</description>
    <arm_group_label>Cigarette smokers</arm_group_label>
    <arm_group_label>Electronic cigarette users</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECIG Lab Session 15 watts, 15 mg nicotine</intervention_name>
    <description>During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.).</description>
    <arm_group_label>Cigarette smokers</arm_group_label>
    <arm_group_label>Electronic cigarette users</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECIG Lab Session 15 watts, 30 mg nicotine</intervention_name>
    <description>During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.</description>
    <arm_group_label>Cigarette smokers</arm_group_label>
    <arm_group_label>Electronic cigarette users</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECIG Lab Session 30 watts, 10 mg nicotine</intervention_name>
    <description>During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.</description>
    <arm_group_label>Cigarette smokers</arm_group_label>
    <arm_group_label>Electronic cigarette users</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECIG Lab Session 30 watts, 15 mg nicotine</intervention_name>
    <description>During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.</description>
    <arm_group_label>Cigarette smokers</arm_group_label>
    <arm_group_label>Electronic cigarette users</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ECIG Lab Session 30 watts, 30 mg nicotine</intervention_name>
    <description>During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.</description>
    <arm_group_label>Cigarette smokers</arm_group_label>
    <arm_group_label>Electronic cigarette users</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria--participants must be:&#xD;
&#xD;
          -  healthy (determined by self-report)&#xD;
&#xD;
          -  between the ages of 18-55&#xD;
&#xD;
          -  willing to provide informed consent&#xD;
&#xD;
          -  able to attend the lab and abstain from tobacco/nicotine as required and must agree to&#xD;
             use designated products according to study protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at&#xD;
             screening.&#xD;
&#xD;
          -  Individuals who weigh less than 110 pounds&#xD;
&#xD;
        Some study details about the eligibility criteria are purposely omitted at this time to&#xD;
        preserve scientific integrity. Full details will be posted at the conclusion of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alison Breland, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Behavioral Pharmacolgy Laboratory</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 9, 2018</study_first_submitted>
  <study_first_submitted_qc>October 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2018</study_first_posted>
  <results_first_submitted>February 9, 2021</results_first_submitted>
  <results_first_submitted_qc>April 28, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 20, 2021</results_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 4, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/90/NCT03710590/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 17, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/90/NCT03710590/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Not-completed reason was not stored by treatment arm</recruitment_details>
      <pre_assignment_details>Each participant will participate in 6 sessions. Sessions differ by the tobacco product used (see study arms). The sessions are ordered by latin-square; however, session order was NOT expected to change any outcomes and order effects are not relevant to the study. Therefore all outcome data was merged and analyzed only by arm and session without regard to order.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cigarette Smokers</title>
          <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
        </group>
        <group group_id="P2">
          <title>E-cigarette Users</title>
          <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to follow up, study stopped due to COVID-19, other reasons</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cigarette Smokers</title>
          <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
        </group>
        <group group_id="B2">
          <title>E-cigarette Users</title>
          <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="27"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.67" spread="8.74"/>
                    <measurement group_id="B2" value="25.40" spread="7.94"/>
                    <measurement group_id="B3" value="29.07" spread="9.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Plasma Nicotine</title>
        <description>Change in plasma nicotine level.</description>
        <time_frame>Baseline to 5 min after the start of a 10-puff product use</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cigarette Smokers</title>
            <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
          </group>
          <group group_id="O2">
            <title>E-cigarette Users</title>
            <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Plasma Nicotine</title>
          <description>Change in plasma nicotine level.</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10mg 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.68" spread="7.22"/>
                    <measurement group_id="O2" value="8.28" spread="9.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10mg 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.53" spread="7.53"/>
                    <measurement group_id="O2" value="12.00" spread="10.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15mg 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.34" spread="6.19"/>
                    <measurement group_id="O2" value="7.17" spread="6.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15mg 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.04" spread="13.14"/>
                    <measurement group_id="O2" value="14.04" spread="12.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30mg 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.18" spread="9.28"/>
                    <measurement group_id="O2" value="20.12" spread="22.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30mg 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.28" spread="18.05"/>
                    <measurement group_id="O2" value="22.38" spread="21.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Puff Volume</title>
        <description>The average volume of each puff, in ml, during 10 puff bout.</description>
        <time_frame>Each time the e-cigarette is used during the 10-puff use bout - 5 minutes</time_frame>
        <population>One participant did not have data for this measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Cigarette Smokers</title>
            <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
          </group>
          <group group_id="O2">
            <title>E-cigarette Users</title>
            <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
          </group>
        </group_list>
        <measure>
          <title>Puff Volume</title>
          <description>The average volume of each puff, in ml, during 10 puff bout.</description>
          <population>One participant did not have data for this measure.</population>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 mg, 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="457.27" spread="223.02"/>
                    <measurement group_id="O2" value="748.34" spread="412.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 mg, 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="245.11" spread="124.09"/>
                    <measurement group_id="O2" value="503.43" spread="216.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 mg, 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="350.18" spread="190.97"/>
                    <measurement group_id="O2" value="708.62" spread="300.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 mg, 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="217.01" spread="94.99"/>
                    <measurement group_id="O2" value="409.56" spread="208.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 mg, 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="310.95" spread="199.06"/>
                    <measurement group_id="O2" value="631.23" spread="225.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 mg, 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="176.32" spread="79.76"/>
                    <measurement group_id="O2" value="415.85" spread="186.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Puff Duration</title>
        <description>The average duration of each puff, in seconds.</description>
        <time_frame>Each time the e-cigarette is used during the 10-puff use bout - 5 minutes</time_frame>
        <population>One participant did not have data collected for this measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Cigarette Smokers</title>
            <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
          </group>
          <group group_id="O2">
            <title>E-cigarette Users</title>
            <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
          </group>
        </group_list>
        <measure>
          <title>Puff Duration</title>
          <description>The average duration of each puff, in seconds.</description>
          <population>One participant did not have data collected for this measure.</population>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 mg, 15 W</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.04" spread="1.01"/>
                    <measurement group_id="O2" value="4.37" spread="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 mg, 30 W</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.97" spread="0.65"/>
                    <measurement group_id="O2" value="2.83" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 mg, 15 W</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.59" spread="0.53"/>
                    <measurement group_id="O2" value="4.02" spread="1.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 mg, 30 W</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.65" spread="0.43"/>
                    <measurement group_id="O2" value="2.72" spread="1.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 mg, 15 W</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.44" spread="0.83"/>
                    <measurement group_id="O2" value="3.41" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 mg, 30 W</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.58" spread="0.45"/>
                    <measurement group_id="O2" value="2.45" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate</title>
        <description>Average heart rate, measured in beats per minute.</description>
        <time_frame>Heart rate will be measured from baseline continuously throughout the 10-puff bout - 5 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cigarette Smokers</title>
            <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
          </group>
          <group group_id="O2">
            <title>E-cigarette Users</title>
            <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>Average heart rate, measured in beats per minute.</description>
          <units>bpm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 mg, 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.66" spread="6.88"/>
                    <measurement group_id="O2" value="75.01" spread="10.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 mg, 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.19" spread="7.25"/>
                    <measurement group_id="O2" value="79.92" spread="15.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 mg, 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.64" spread="6.32"/>
                    <measurement group_id="O2" value="79.09" spread="15.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 mg, 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.05" spread="6.91"/>
                    <measurement group_id="O2" value="80.27" spread="12.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 mg, 15 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.12" spread="8.83"/>
                    <measurement group_id="O2" value="78.56" spread="12.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 mg, 30 Watts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.12" spread="8.95"/>
                    <measurement group_id="O2" value="84.51" spread="14.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Inter Puff Interval</title>
        <description>The time between each puff, in seconds</description>
        <time_frame>Inter puff interval will be measured each time the e-cigarette is used during an approximately 4 hour session: during a 5-minute 10-puff use bout, and during an approximately 90 minute ad lib use period</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Flow Rate</title>
        <description>The rate of air flow during each puff, in ml/second</description>
        <time_frame>Flow rate will be measured each time the e-cigarette is used during an approximately 4 hour session: during a 5-minute 10-puff use bout, and during an approximately 90 minute ad lib use period</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Hughes-Hatsukami Questionnaire</title>
        <description>This scale is used to assess the extent to which product use reduces tobacco abstinence symptoms, and consists of 11 items scored 0 - 100, with lower scores indicating less severe symptoms. There are no sub-scales. Items are analyzed separately.</description>
        <time_frame>Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Direct Effects of Product Use Questionnaire</title>
        <description>This scale is used to assess how product use makes participants feel and consists of 10 questions that are scored 0 - 100. There are no sub-scales. Items are analyzed separately.</description>
        <time_frame>Questionnaire will be administered 2 times in each each approximately 4-hr session: 10 minutes after the start of a 10-puff use bout, and then after an approximately 1-hour ad lib use period.</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Direct Effects of Nicotine Questionnaire</title>
        <description>This scale is used to assess how product use makes participants feel, and consists of 10 questions that are scored 0 - 100.There are no sub-scales. Items are analyzed separately.</description>
        <time_frame>Questionnaire will be administered 4 times in each each approximately 4-hr session: before any product use, 10 minutes after the start of a 10-puff use bout, and then before and after an approximately 1-hour ad lib use period.</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Carbon Monoxide Levels</title>
        <description>Change in carbon monoxide levels (in parts per mission)</description>
        <time_frame>Carbon monoxide levels will be assessed before and after product use in each approximately 4-hr session: at baseline, 5 min after the end of a 10-puff product use, and then before and after an approximately 1-hour ad lib use period.</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Blood Pressure</title>
        <description>Change in blood pressure, measured in mm/hg</description>
        <time_frame>Blood pressure will be measured from baseline continuously throughout each approximately 4-hr session</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>General Labeled Magnitude Scale</title>
        <description>This scale measures the flavor sensation, harshness, and throat hit (in three questions that correspond to those constructs) of the e-cigarette used in each session. The scale ranges from 0 - 100, with 0 being no sensation and 100 being the strongest imaginable sensation of any kind. Each item if scored nd analyzed separately (there are no sub-scales).</description>
        <time_frame>The General Labeled Magnitude Scale will be administered twice in each approximately 4 hour session--after a 5-minute 10 puff use bout, and after the approximately 90 minute ad lib period.</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During each of 6 approximately 4-hour session over up to a 3 week period.</time_frame>
      <desc>This study did not have any SAEs or all-cause mortality.</desc>
      <group_list>
        <group group_id="E1">
          <title>Cigarette Smokers</title>
          <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
        </group>
        <group group_id="E2">
          <title>E-cigarette Users</title>
          <description>Each participant will participate in 6 sessions. During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.&#xD;
Session 1: ECIG Lab Session 15 watts, 10 mg nicotine Session 2: ECIG Lab Session 15 watts, 15 mg nicotine Session 3: ECIG Lab Session 15 watts, 30 mg nicotine Session 4: ECIG Lab Session 30 watts, 10 mg nicotine Session 5: ECIG Lab Session 30 watts, 15 mg nicotine Session 6: ECIG Lab Session 30 watts, 30 mg nicotine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Alison Breland</name_or_title>
      <organization>Virginia Commonwealth University</organization>
      <phone>804 628 2300</phone>
      <email>abbrelan@vcu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

